Alignment Healthcare (NASDAQ:ALHC) Insider Andreas Wagner Sells 22,238 Shares

Alignment Healthcare, Inc. (NASDAQ:ALHC) insider Andreas Wagner sold 22,238 shares of the company’s stock in a transaction that occurred on Tuesday, February 10th. The stock was sold at an average price of $20.47, for a total value of $455,211.86. Following the sale, the insider directly owned 169,805 shares in the company, valued at $3,475,908.35. This trade represents a 11.58% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.

Alignment Healthcare Trading Down 1.2%

ALHC stock opened at $20.39 on Thursday. The firm has a fifty day moving average price of $20.88 and a 200 day moving average price of $17.98. Alignment Healthcare, Inc. has a fifty-two week low of $11.63 and a fifty-two week high of $23.87. The firm has a market cap of $4.08 billion, a PE ratio of -169.92, a price-to-earnings-growth ratio of 5.26 and a beta of 1.16. The company has a debt-to-equity ratio of 1.99, a quick ratio of 1.61 and a current ratio of 1.61.

Institutional Investors Weigh In On Alignment Healthcare

Institutional investors and hedge funds have recently modified their holdings of the business. Picton Mahoney Asset Management grew its position in Alignment Healthcare by 2.6% in the 4th quarter. Picton Mahoney Asset Management now owns 404,156 shares of the company’s stock valued at $7,982,000 after acquiring an additional 10,248 shares during the last quarter. Deutsche Bank AG boosted its stake in shares of Alignment Healthcare by 15.0% during the fourth quarter. Deutsche Bank AG now owns 139,297 shares of the company’s stock valued at $2,751,000 after purchasing an additional 18,136 shares during the period. Cerity Partners LLC grew its holdings in shares of Alignment Healthcare by 10.5% in the fourth quarter. Cerity Partners LLC now owns 22,986 shares of the company’s stock worth $454,000 after purchasing an additional 2,180 shares during the last quarter. LPL Financial LLC purchased a new position in Alignment Healthcare in the 4th quarter worth about $703,000. Finally, Capital World Investors bought a new stake in Alignment Healthcare during the 4th quarter valued at about $44,203,000. 86.19% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

A number of research analysts recently commented on the stock. The Goldman Sachs Group reaffirmed a “buy” rating and issued a $22.00 price target on shares of Alignment Healthcare in a report on Monday, November 3rd. UBS Group upped their price objective on Alignment Healthcare from $18.00 to $21.00 and gave the company a “neutral” rating in a research report on Wednesday, January 14th. Piper Sandler lifted their target price on Alignment Healthcare from $20.00 to $30.00 and gave the stock an “overweight” rating in a report on Tuesday, January 6th. KeyCorp reissued an “overweight” rating and set a $28.00 target price on shares of Alignment Healthcare in a research report on Thursday, January 22nd. Finally, Wall Street Zen upgraded Alignment Healthcare from a “hold” rating to a “buy” rating in a research report on Saturday, February 7th. One equities research analyst has rated the stock with a Strong Buy rating, nine have issued a Buy rating, three have assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $23.32.

About Alignment Healthcare

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.